RUBRIK, INC. (RBRK) Spending and interest coverage
- R&D / revenue · 12 months: Value 28.59%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 22.16%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 28.59% | Research and development expense / revenue. Period ending 2026-07-31. $440.96M ÷ $1.54B × 100 ≈ 28.59% |
| Stock-based compensation / revenue · 12 months | 22.16% | Share-based compensation / revenue. Period ending 2026-07-31. $341.76M ÷ $1.54B × 100 ≈ 22.16% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 440.96M USD | Research and Development Expense |
| Revenue | 1.54B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 341.76M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -282.40M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $440.96M | $1.54B | $341.76M | $-282.40M | (m) | 28.59% | 22.16% | (m) | (m) |
| 2026-04-30 | $406.21M | $1.42B | $329.20M | $-304.96M | (m) | 28.51% | 23.11% | (m) | (m) |
| 2026-01-31 | $373.68M | $1.32B | $329.37M | $-345.42M | (m) | 28.39% | 25.02% | (m) | (m) |
| 2025-10-31 | $351.46M | $1.20B | $330.50M | $-379.15M | (m) | 29.37% | 27.62% | (m) | (m) |
| 2025-07-31 | $333.93M | $1.08B | $340.56M | $-428.46M | (m) | 30.84% | 31.46% | (m) | (m) |
| 2025-04-30 | $328.05M | $977.71M | $357.12M | $-502.29M | (m) | 33.55% | 36.53% | (m) | (m) |
| 2025-01-31 | $531.62M | $886.54M | $913.91M | $-1.13B | (m) | 59.96% | 103.09% | (m) | (m) |
| 2024-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | $206.53M | $627.89M | $5.71M | $-306.51M | (m) | 32.89% | 0.91% | (m) | (m) |
| 2023-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-01-31 | $175.06M | $599.82M | $6.95M | $-261.55M | (m) | 29.18% | 1.16% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.